Eastman Chemical Co
EMN: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$516.00 | Lcdvqdz | Kghbskq |
Eastman Chemical Earnings: Profit Growth Exemplifies Our Recovery Thesis
Eastman Chemical's second-quarter results reflected our view for the year of a demand recovery following the economic slowdown in 2023 that weighed on profits. As demand stabilized, Eastman generated a modest 5% year-on-year adjusted operating profit growth. With our outlook largely unchanged, we're maintaining our $125 fair value estimate for Eastman. Our narrow-moat rating is also unchanged.